Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05319847 · ClinicalTrials.gov registry record · NA

An Exploratory Investigation of a Male Focused Skincare Supplement

A NA study of Acne and Skin Abnormalities, sponsored by Let's Dis.

Completed
Registry status
NA
Development phase
38
Enrollment target
1
Study location

NCT05319847 is a NA study of Acne and Skin Abnormalities that has completed, run by Let's Dis. The registered enrollment target is 38 participants, below the 141-participant average among 26 other Acne trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05319847, a NA study of Acne and Skin Abnormalities, has completed, sponsored by Let's Dis.

COMPLETED
Registry status
NA
Development phase
38 participants
Enrollment target
1
Study location

Study Summary

Most skincare products on the market are topical and do not take a holistic approach to understanding skin health. This trial will examine a dietary supplement designed to support the gut microbiome and promote skin health from an internal perspective. Research has previously supported the link between the gut microbiome and skin health and the supplement tested in this trial will further the knowledge on the effectiveness of supporting gut health to improve skin outcomes.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Daily Skin Supplement - Fountain of Youth

Study Locations (1)

California

  • Citruslabs - Santa Monica

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2022-04-15
Est. Completion 2022-06-30
Phase NA

Sponsor

Let's Dis

1 total trials

What the Registry Record Tells You About NCT05319847

The ClinicalTrials.gov registry entry for NCT05319847 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 141-participant average among 26 other Acne trials with a reported enrollment target (73% lower). The listed sponsor is Let's Dis, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Acne appearing as the primary indexed condition, and to 1 intervention - of which Daily Skin Supplement - Fountain of Youth is the first listed.

NCT05319847 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05319847 about?

NCT05319847 is a clinical study titled "An Exploratory Investigation of a Male Focused Skincare Supplement". Most skincare products on the market are topical and do not take a holistic approach to understanding skin health. This trial will examine a dietary supplement designed to support the gut microbiome and promote skin health from an internal perspective. Research has previously supported the link betw...

What is the current status of trial NCT05319847?

This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2022-04-15. Estimated completion is 2022-06-30.

What conditions does trial NCT05319847 study?

This clinical trial studies the following conditions: Acne, Skin Abnormalities.

What interventions are being tested in trial NCT05319847?

The interventions under investigation include: Daily Skin Supplement - Fountain of Youth (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05319847?

This trial is sponsored by Let's Dis, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05319847 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acne

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.